DierenDokters has been acquired by VetPartners
DierenDokters, a leading group of fourteen veterinary clinics located across the Netherlands, has been acquired by VetPartners, a UK-based group of over 650 veterinary clinics and hospitals located across Europe. By partnering with VetPartners, DierenDokters welcomes a strong new shareholder that will help further enhance DierenDokters’ clinics’ service offering and allow the clinics to continue focusing on providing the best possible animal healthcare services.
Founded in 2004, DierenDokters offers a comprehensive range of primary animal care services, complemented by each clinic having its own specific focus on multiple and more complex veterinary conditions. By leveraging its strong branding and online presence, continuous compliance monitoring on standard of care, price monitoring and dedicated focus on customer communication, DierenDokters holds a strong position in the Dutch veterinary services market.
Established in October 2015, VetPartners, a portfolio company of European private equity firm BC Partners, is made up of some of the UK’s most respected and trusted small animal, equine, mixed and farm practices and production animal health businesses. The acquisition of DierenDokters enables VetPartners to expand into another European country, the Netherlands.
Oaklins’ team in the Netherlands acted as the exclusive M&A sell-side advisor to the shareholders of DierenDokters. This transaction emphasizes Oaklins’ strong track record and expertise in the healthcare clinics and consumer & retail sectors.
Jeroen Dreuw and Maico Boumans
Former shareholders and co-founders, DierenDokters
Sprechen Sie mit dem Deal Team
Marc van de Put
Oaklins Netherlands
Transaktionen
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Mehr erfahrenDie Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahrenArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Mehr erfahren